Table 1.
Molecular target | Drug/Small molecule | Mode of action |
---|---|---|
Sirtuins | Resveratrol | ? Direct/indirect STAC |
SRT1720/2104 | Direct sirtuin activator | |
Nicotinamide riboside | NAD precursor | |
Apigenin | Inhibits CD38, enzyme that degrades NAD | |
mTOR | Rapamycin/Sirolimus/ Everolimus | Rapamycin and rapalogs/mTORC1 inhibitors |
AZD8055/INK128 | Direct mTOR kinase inhibitors | |
IIS/GH | Pegvisomant | GH receptor antagonist |
Trametinib | Ras inhibitor resulting in decreased IIS signaling | |
AMPK and others | Metformin | Potential AMPK activator |
Ruxolitinib | JAK inhibitor/↓ inflammation | |
Spermidine | Natural product ↑ autophagy | |
Quescetin/Dasatinib | Senolytics |